On Wednesday, Biocon stock slipped 0.55 per cent to settle at Rs 364.55 apiece on the BSE.

According to Axis Securities, the reduction in reciprocal taxes is incrementally positive for Indian pharmaceutical companies, particularly those with significant exposure to the US market, ...

Biocon has completed the acquisition of the remaining equity shares of its unlisted subsidiary Biocon Biologics from Mylan ...

Analyst revisions kept stocks of Zomato, Biocon, and ONGC in focus on Monday. While Zomato’s share price was down by 4.8% after Jefferies downgraded the stock to “hold”, Biocon’s share price was ...

Shares of companies related to pharmaceuticals sector jumped on Sunday after Finance Minister Nirmala Sitharaman proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a ...

I write about Asia's richest, fast-growing businesses, and startups. Biocon—controlled by Indian pharmaceutical billionaire Kiran Mazumdar-Shaw—is buying the rest of privately held subsidiary Biocon ...

HYDERABAD, Jan 31 (Reuters) - Indian biopharmaceutical firm Biocon (BION.NS), opens new tab is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S ...

Biocon Ltd on Monday said its wholly owned subsidiary, Biocon Pharma Ltd, has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S's Ozempic and Wegovy in key markets as patents on the blockbuster weight-loss drugs expire next year. The ...

Budget 2024 proposes Rs 10,000 crore investment in biopharma. Anthem Biosciences, Biocon stocks jump. Impact on pharma sector ...

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...